Foresight Group — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Inovivinoviv.cominApr 2024
Inoviv provides custom multiplexed LC-MS proteomics panels for biomarker discovery and analysis in drug discovery and development.
BiotechDeep TechHealthtechMedical DevicesLondon, GB
Ernestas Sirka(CSO)inMichael Dove(Founding CEO)in
Co-investorsBeast VenturesEntrepreneur FirstHoxton Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.